Telangana minister launches 5 projects at Genome Valley
Real Estate

Telangana minister launches 5 projects at Genome Valley

The five projects involve a cumulative investment of Rs 11 billion
Heralding a new phase of development at the life sciences cluster Genome Valley, Telangana Industries Minister K T Rama Rao his week laid the foundation stone for five projects involving a cumulative investment of Rs 11 billion and having the potential to create 3,000 jobs.

These also include the Biopharma Hub (B-Hub), a PPP project of Telangana government, Telangana State Industrial Infrastructure Corporation (TSIIC), and the Department of Biotechnology. This aims at catalysing the biopharmaceuticals sector.

Rama Rao said the demand for space at Genome Valley was on the rise. “We have a good problem on hand. We are running out of space at the cluster,” he said, adding that various developments and expansions happening would add about 2 million sq ft space in the next two years or so.

Over 200 biotechnology, life sciences and pharmaceutical companies operate from Genome Valley, India’s first organised research and development cluster. It has more plug-and-play facilities than all other clusters put together. Various companies including Biological E Ltd and Indian Immunologicals have announced investments worth Rs 25 billion to increase vaccine manufacturing capacities. Homegrown pharmaceutical company Hetero will spend Rs 7.50 billion to set up sterile pharmaceutical products while global giant Roche is setting up its analytics and technology centre in Hyderabad.

See also:
Volcan Investments, not Vedanta, to invest in semi-conductor plant
MeitY Startup Hub, Meta collaborate to accelerate XR startups


The five projects involve a cumulative investment of Rs 11 billion Heralding a new phase of development at the life sciences cluster Genome Valley, Telangana Industries Minister K T Rama Rao his week laid the foundation stone for five projects involving a cumulative investment of Rs 11 billion and having the potential to create 3,000 jobs. These also include the Biopharma Hub (B-Hub), a PPP project of Telangana government, Telangana State Industrial Infrastructure Corporation (TSIIC), and the Department of Biotechnology. This aims at catalysing the biopharmaceuticals sector. Rama Rao said the demand for space at Genome Valley was on the rise. “We have a good problem on hand. We are running out of space at the cluster,” he said, adding that various developments and expansions happening would add about 2 million sq ft space in the next two years or so. Over 200 biotechnology, life sciences and pharmaceutical companies operate from Genome Valley, India’s first organised research and development cluster. It has more plug-and-play facilities than all other clusters put together. Various companies including Biological E Ltd and Indian Immunologicals have announced investments worth Rs 25 billion to increase vaccine manufacturing capacities. Homegrown pharmaceutical company Hetero will spend Rs 7.50 billion to set up sterile pharmaceutical products while global giant Roche is setting up its analytics and technology centre in Hyderabad. See also: Volcan Investments, not Vedanta, to invest in semi-conductor plantMeitY Startup Hub, Meta collaborate to accelerate XR startups

Related Stories

Gold Stories

Next Story
Resources

Schindler named among Forbes’ World’s Best Employers 2026

Schindler has been named among Forbes’ World’s Best Employers 2026, a global ranking recognising companies for their workplace environments.Compiled by Forbes in partnership with Statista, the ranking is based on independent employee feedback, including whether employees would recommend their organisation to friends and family.The company said the recognition reflected its focus on creating a workplace where employees can develop their expertise and build careers. ..

Next Story
Infrastructure Urban

India needs an export-execution mindset: Vishesh Jain

Interview with Vishesh Jain, Founder & CEO, EximpleWhat gaps in India’s global trade ecosystem led you to build Eximple, and what problem did you see businesses struggling with most?Eximple came out of a problem that all three founders had seen from different choke points in the trade ecosystem. India has millions of MSMEs and manufacturers, and many of them can make products that are genuinely competitive on quality. Yet only a small fraction is able to build meaningful international businesses. In our experience, the gap is usually not manufacturing capability; it is the ability to exe..

Next Story
Building Material

Nuvoco reports 13.5% revenue growth in Q2 FY27

Nuvoco Vistas Corp. Ltd. reported consolidated revenue of Rs 27.9 billion for Q2 FY27, up 13.5% year on year. Cement sales volume rose 9% to 4.7 million tonnes (MMT), while EBITDA increased 11% to Rs 4.11 billion.The company said it began its cement operations in 2014 with a 2.3 MMT per annum (MMTPA) operation at Nimbol. It now aims to reach 35 MMTPA of cement capacity by FY28, nearly 15 times its initial capacity. Its portfolio spans cement, ready-mix concrete and modern building materials.On sustainability and cost efficiency, Nuvoco partnered with CleanMax for a 46.4 MW wind-solar hybrid re..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code